Clinical Trials Update: Oct. 10, 2006
Vaccines Miscarriage Speech Disorders
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
This is a clinical research study involving a higher-dose influenza (flu) vaccination. To qualify, you must be 65 or older, in good health, not had a recent flu vaccine, and not participated in a prior high-dose flu vaccine study.
The research site is in Tucson, Ariz.
This clinical study will evaluate whether intravenous immunoglobulin (IVIG) improves the live birth rate in couples who have had secondary recurrent miscarriage. Women 18-44 with a history of a successful pregnancy followed by at least three miscarriages, all conceived with the same partner, may qualify. To be eligible, genetic, endocrine, anatomical, and autoimmune factors associated with recurrent miscarriage must be ruled out.
The research site is in Chicago, Ill.
Aging of the vocal cords leads to deterioration of the voice, most commonly in males. This study will investigate a possible therapy. You may be eligible if you are a male over age 65 and have a weakened voice.
The research site is in Lexington, Ky.
Copyright 2006 Thomson CenterWatch. All rights reserved.